Helius Medical Technologies Inc Class A

NASDAQ HSDT
$5.94 -0.05 -0.92%
Today share price
USA
Sector: Healthcare Industry: Medical Devices
Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Rating Finrange

Index: 25 %
Market cap Market capitalization – refers to the total value of all a company's shares of stock. It is calculated by multiplying the price of a stock by its total number of outstanding shares.
3.03M
EV Enterprise value is a measure of a company's total value, often used as a more comprehensive alternative to equity market capitalization. Enterprise value includes in its calculation the market capitalization of a company but also short-term and long-term debt as well as any cash on the company's balance sheet.
1.92M
Beta Beta is one of the most popular indicators of risk is a statistical measure. Analysts use this measure often when they need to determine a stock's risk profile.
-
Shares Shares outstanding refer to a company's stock currently held by all its shareholders, including share blocks held by institutional investors and restricted shares owned by the company’s insiders.
7.56M
YTD Year to date (YTD) refers to the period of time beginning the first day of the current calendar year or fiscal year up to the current date. he acronym often modifies concepts such as investment returns and price change.
786.17 %

Upcoming events Helius Medical Technologies Inc Class A

All events
No upcoming events scheduled

Stock chart Helius Medical Technologies Inc Class A

Stock analysis Helius Medical Technologies Inc Class A

Indicator Company Industry
P/E (LTM) Shows how many years the investor's investment in the company will pay off with a profit over the last 12 months.
-0.23 -2.59
P/BV (LTM) Shows the ratio of the market price of the share to the current book value.
1.72 1.36
EV/EBITDA (LTM) Represents the ratio of the company's value to its pre-tax EBITDA in the last 12 months.
-0.15 -2.52
Net Debt/EBITDA (LTM) A company's debt ratio, which indicates how long the company will need to run on cash flow in the past 12 months to pay off its own debt.
0.09 0.34
ROE (LTM) Shows the efficiency of using the share capital by the company. In other words, ROE shows how much of the company's net profit for the invested capital over the last 12 months.
-1020.63 -40.86

Price change Helius Medical Technologies Inc Class A per year

0.18$ 9.76$
Min Max

Summary analysis Helius Medical Technologies Inc Class A

Get access
to the rating of Finrange stocks
With this tariff you will be able to use the service without restrictions, all information will be available
Get 7 days free

Shareholder structure Helius Medical Technologies Inc Class A

Revenue and net income Helius Medical Technologies Inc Class A

All parameters

About company Helius Medical Technologies Inc Class A

Helius Medical Technologies, Inc., a neurotechnology company, focuses on developing, licensing, and acquiring non-implantable technologies for the treatment of symptoms caused by neurological disease or trauma. The company's product is Portable Neuromodulation Stimulator, a non-surgical medical device intended for use as a short term treatment of gait deficit due to symptoms from multiple sclerosis and balance deficit due to mild-to-moderate traumatic brain injury, as well as to be used in conjunction with supervised therapeutic exercise. Helius Medical Technologies, Inc. was incorporated in 2014 and is headquartered in Newtown, Pennsylvania.
Address:
642 Newtown Yardley Road, Newtown, PA, United States, 18940
Company name: Helius Medical Technologies Inc Class A
Issuer ticker: HSDT
ISIN: US42328V6039
Country: USA
Exchange: NASDAQ
Currency: $
IPO date: 2014-06-27
Sector: Healthcare
Industry: Medical Devices
Site: https://heliusmedical.com